-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.
-
Summary
-
Neuphoria Therapeutics Inc. quarterly Deferred Income Tax Liabilities, Net history and change rate from Q2 2023 to Q3 2025.
- Neuphoria Therapeutics Inc. Deferred Income Tax Liabilities, Net for the quarter ending 30 Sep 2025 was $460,320, a 44.6% decline year-over-year.
Deferred Income Tax Liabilities, Net, Quarterly (USD)
Deferred Income Tax Liabilities, Net, YoY Quarterly Change (%)